Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Keystone

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|May 17, 2011
Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm dataEdward C Keystone
Current Opinion in Rheumatology|April 23, 2003
Abandoned therapies and unpublished trials in rheumatoid arthritisEdward C Keystone
The Journal of Rheumatology. Supplement|March 3, 2005
Safety of biologic therapies--an updateEdward C Keystone
Nature Clinical Practice. Rheumatology|November 1, 2006
Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomesEdward C Keystone
The Journal of Rheumatology|May 5, 2010
Are physician-derived joint counts obsolete?Edward C Keystone
The Journal of Rheumatology. Supplement|June 11, 2009
Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritisEdward C Keystone
Nature Clinical Practice. Rheumatology|February 1, 2008
Tight control for the management of RA--a therapeutic approach worth pursuingEdward C Keystone
Nature Clinical Practice. Rheumatology|July 9, 2008
Is a step-down regimen more effective than a step-up regimen in the treatment of early rheumatoid arthritis?Edward C Keystone
Drugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Appropriate and effective rheumatoid arthritis control: role of TNF antagonistsEdward C Keystone
Nature Clinical Practice. Rheumatology|November 1, 2006
Switching tumor necrosis factor inhibitors: an opinionEdward C Keystone
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|May 17, 2011
Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm dataEdward C Keystone
Current Opinion in Rheumatology|April 23, 2003
Abandoned therapies and unpublished trials in rheumatoid arthritisEdward C Keystone
The Journal of Rheumatology. Supplement|March 3, 2005
Safety of biologic therapies--an updateEdward C Keystone
Nature Clinical Practice. Rheumatology|November 1, 2006
Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomesEdward C Keystone
The Journal of Rheumatology|May 5, 2010
Are physician-derived joint counts obsolete?Edward C Keystone
The Journal of Rheumatology. Supplement|June 11, 2009
Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritisEdward C Keystone
Nature Clinical Practice. Rheumatology|February 1, 2008
Tight control for the management of RA--a therapeutic approach worth pursuingEdward C Keystone
Nature Clinical Practice. Rheumatology|July 9, 2008
Is a step-down regimen more effective than a step-up regimen in the treatment of early rheumatoid arthritis?Edward C Keystone
Drugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Appropriate and effective rheumatoid arthritis control: role of TNF antagonistsEdward C Keystone
Nature Clinical Practice. Rheumatology|November 1, 2006
Switching tumor necrosis factor inhibitors: an opinionEdward C Keystone
Pageof 16